BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Finsterer J. Treatment of central nervous system manifestations in mitochondrial disorders: Treatment of mitochondrial disorders. European Journal of Neurology 2011;18:28-38. [DOI: 10.1111/j.1468-1331.2010.03086.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Finsterer J, Frank M. Beneficial effect of lacosamide for mitochondrial epilepsy. Epilepsy Res 2018;140:95-6. [PMID: 29316502 DOI: 10.1016/j.eplepsyres.2017.12.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
2 Wen Y. Maxwell's demon at work: Mitochondria, the organelles that convert information into energy? Chronic Dis Transl Med 2018;4:135-8. [PMID: 29988942 DOI: 10.1016/j.cdtm.2018.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Orsucci D, Ienco EC, Siciliano G, Mancuso M. Mitochondrial disorders and drugs: what every physician should know. Drugs Context 2019;8:212588. [PMID: 31391854 DOI: 10.7573/dic.212588] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
4 Finsterer J, Carvalho EHTD. Cerebral Manifestations of Mitochondrial Disorders. Can J Neurol Sci 2017;44:654-63. [DOI: 10.1017/cjn.2017.211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lee IC, Chiang KL. Clinical Diagnosis and Treatment of Leigh Syndrome Based on SURF1: Genotype and Phenotype. Antioxidants (Basel) 2021;10:1950. [PMID: 34943053 DOI: 10.3390/antiox10121950] [Reference Citation Analysis]
6 Dechandt CRP, Vicentini TM, Lanfredi GP, Silva-Jr RMP, Espreafico EM, de Oliveira JAC, Faça VM, Garcia-Cairasco N, Alberici LC. The highly efficient powerhouse in the Wistar audiogenic rat, an epileptic rat strain. Am J Physiol Regul Integr Comp Physiol 2019;316:R243-54. [PMID: 30517024 DOI: 10.1152/ajpregu.00254.2018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Mancuso M, Orsucci D, Filosto M, Simoncini C, Siciliano G. Drugs and mitochondrial diseases: 40 queries and answers. Expert Opinion on Pharmacotherapy 2012;13:527-43. [DOI: 10.1517/14656566.2012.657177] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
8 Finsterer J, Chatterjee S. Chiropractic-Responsive Vestibular Involvement in Mitochondrial Disorders. J Chiropr Med 2020;19:260-1. [PMID: 33536863 DOI: 10.1016/j.jcm.2019.09.003] [Reference Citation Analysis]
9 Liu CH, Chang CH, Kuo HC, Ro LS, Liou CW, Wei YH, Huang CC. Prognosis of symptomatic patients with the A3243G mutation of mitochondrial DNA. J Formos Med Assoc 2012;111:489-94. [PMID: 23021505 DOI: 10.1016/j.jfma.2011.06.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
10 Ogłodek EA, Just MJ, Szromek AR, Araszkiewicz A. Melatonin and neurotrophins NT-3, BDNF, NGF in patients with varying levels of depression severity. Pharmacol Rep 2016;68:945-51. [PMID: 27367919 DOI: 10.1016/j.pharep.2016.04.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
11 Ryzhkova AI, Sazonova MA, Sinyov VV, Galitsyna EV, Chicheva MM, Melnichenko AA, Grechko AV, Postnov AY, Orekhov AN, Shkurat TP. Mitochondrial diseases caused by mtDNA mutations: a mini-review. Ther Clin Risk Manag 2018;14:1933-42. [PMID: 30349272 DOI: 10.2147/TCRM.S154863] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
12 Thomas T, Craigen WJ, Moore R, Czosek R, Jefferies JL. Arrhythmia as a cardiac manifestation in MELAS syndrome. Mol Genet Metab Rep 2015;4:9-10. [PMID: 26937404 DOI: 10.1016/j.ymgmr.2015.05.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
13 Gardner A, Boles RG. Comment on Treatment of Psychiatric Illness in Patients with Mitochondrial Disease. Psychosomatics 2011;52:497-8. [DOI: 10.1016/j.psym.2011.01.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
14 Finsterer J, Zarrouk-Mahjoub S. Ophthalmologic involvement in mitochondrial disorders. Ophthalmic Genet 2017;38:298. [PMID: 27428825 DOI: 10.1080/13816810.2016.1199714] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]